Gulzeb Memon

Gulzeb Memon practices at MedStar Harbor Hospital in Baltimore, Maryland, part of MedStar Health.

Gulzeb Memon's NPI, 1124503198, was assigned on September 26, 2018. Gulzeb Memon holds Maryland license D0099853.

Gulzeb Memon's primary practice is MedStar Harbor Hospital, at 3001 South Hanover Street, Baltimore, MD 21225 in Baltimore City. The practice phone is (410) 350-3201.

Gulzeb Memon's primary practice is MedStar Harbor Hospital in Baltimore, Maryland, part of MedStar Health. Gulzeb Memon is also affiliated with Luminis Health Anne Arundel Medical Center. The medical group on file is MedStar Medical Group. Dmand AI also links Gulzeb Memon to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Gulzeb Memon practices, 4 sites in all. Vendor and product names are available with a free account.

Hospitalist is Gulzeb Memon's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Gulzeb Memon is licensed in Maryland.

CMS data shows 106 Medicare services from Gulzeb Memon across 2 procedure codes in 2024, for 111 Medicare patients. Medicare paid $14,144 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 111 Medicare patients who saw Gulzeb Memon in 2024. The largest group is 75 to 84, with 35 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Gulzeb Memon's median patient age at 61, with 52% women.

In 2024, Gulzeb Memon wrote 70 Medicare Part D claims for 31 patients. 80% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $28 in total drug cost. In 2019, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Gulzeb Memon for performance year 2024, reported as part of a group. Gulzeb Memon accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Gulzeb Memon from 1 drug or device company from 2023 to 2024. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $48.